Rockwell Medical Capital Expenditures (CapEx) Growth & History (RMTI)
Rockwell Medical's capital expenditures (capex) was $542,000 for fiscal 2025.
View full Rockwell Medical company overviewRockwell Medical annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $542,000 | −$469,000 | −46.39% |
| 2024 | 2024-12-31 | $1.0M | $727,000 | +255.99% |
| 2023 | 2023-12-31 | $284,000 | $3,000 | +1.07% |
| 2022 | 2022-12-31 | $281,000 | −$241,000 | −46.17% |
| 2021 | 2021-12-31 | $522,000 | −$524,000 | −50.10% |
| 2020 | 2020-12-31 | $1.0M | $458,000 | +77.89% |
| 2019 | 2019-12-31 | $588,000 | −$156,256 | −20.99% |
| 2018 | 2018-12-31 | $744,256 | −$938,657 | −55.78% |
| 2017 | 2017-12-31 | $1.7M | $1.3M | +373.71% |
| 2016 | 2016-12-31 | $355,264 | −$459,738 | −56.41% |
| 2015 | 2015-12-31 | $815,002 | $130,409 | +19.05% |
| 2014 | 2014-12-31 | $684,593 | $30,396 | +4.65% |
| 2013 | 2013-12-31 | $654,197 | $146,409 | +28.83% |
| 2012 | 2012-12-31 | $507,788 | −$58,376 | −10.31% |
| 2011 | 2011-12-31 | $566,164 | −$206,200 | −26.70% |
| 2010 | 2010-12-31 | $772,364 | −$828,584 | −51.76% |
| 2009 | 2009-12-31 | $1.6M | — | — |
Rockwell Medical quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $617,000 | $453,000 | +276.22% |
| Q1 2026 | 2026-03-31 | $425,000 | $362,000 | +574.60% |
| Q4 2025 | 2025-12-31 | $86,000 | −$309,000 | −78.23% |
| Q3 2025 | 2025-09-30 | $229,000 | $38,000 | +19.90% |
| Q2 2025 | 2025-06-30 | $164,000 | −$122,000 | −42.66% |
| Q1 2025 | 2025-03-31 | $63,000 | −$76,000 | −54.68% |
| Q4 2024 | 2024-12-31 | $395,000 | — | — |
| Q3 2024 | 2024-09-30 | $191,000 | — | — |
| Q2 2024 | 2024-06-30 | $286,000 | $206,000 | +257.50% |
| Q1 2024 | 2024-03-31 | $139,000 | −$6,000 | −4.14% |
| Q2 2023 | 2023-06-30 | $80,000 | $29,000 | +56.86% |
| Q1 2023 | 2023-03-31 | $145,000 | $116,000 | +400.00% |
| Q4 2022 | 2022-12-31 | $84,000 | −$30,000 | −26.32% |
| Q3 2022 | 2022-09-30 | $117,000 | −$10,000 | −7.87% |
| Q2 2022 | 2022-06-30 | $51,000 | −$192,000 | −79.01% |
| Q1 2022 | 2022-03-31 | $29,000 | −$9,000 | −23.68% |
| Q4 2021 | 2021-12-31 | $114,000 | $38,000 | +50.00% |
| Q3 2021 | 2021-09-30 | $127,000 | −$560,000 | −81.51% |
| Q2 2021 | 2021-06-30 | $243,000 | $163,000 | +203.75% |
| Q1 2021 | 2021-03-31 | $38,000 | −$165,000 | −81.28% |
| Q4 2020 | 2020-12-31 | $76,000 | −$63,000 | −45.32% |
| Q3 2020 | 2020-09-30 | $687,000 | $543,030 | +377.18% |
| Q2 2020 | 2020-06-30 | $80,000 | −$103,204 | −56.33% |
| Q1 2020 | 2020-03-31 | $203,000 | $81,174 | +66.63% |
| Q4 2019 | 2019-12-31 | $139,000 | −$15,715 | −10.16% |
| Q3 2019 | 2019-09-30 | $143,970 | −$104,771 | −42.12% |
| Q2 2019 | 2019-06-30 | $183,204 | −$1,884 | −1.02% |
| Q1 2019 | 2019-03-31 | $121,826 | −$33,886 | −21.76% |
| Q4 2018 | 2018-12-31 | $154,715 | −$821,852 | −84.16% |
| Q3 2018 | 2018-09-30 | $248,741 | −$56,550 | −18.52% |
| Q2 2018 | 2018-06-30 | $185,088 | −$53,964 | −22.57% |
| Q1 2018 | 2018-03-31 | $155,712 | −$6,291 | −3.88% |
| Q4 2017 | 2017-12-31 | $976,567 | $949,625 | +3524.70% |
| Q3 2017 | 2017-09-30 | $305,291 | $206,256 | +208.27% |
| Q2 2017 | 2017-06-30 | $239,052 | $212,195 | +790.09% |
| Q1 2017 | 2017-03-31 | $162,003 | −$40,427 | −19.97% |
| Q4 2016 | 2016-12-31 | $26,942 | −$451,204 | −94.37% |
| Q3 2016 | 2016-09-30 | $99,035 | −$29,208 | −22.78% |
| Q2 2016 | 2016-06-30 | $26,857 | −$104,051 | −79.48% |
| Q1 2016 | 2016-03-31 | $202,430 | $124,725 | +160.51% |
| Q4 2015 | 2015-12-31 | $478,146 | $406,864 | +570.78% |
| Q3 2015 | 2015-09-30 | $128,243 | −$56,237 | −30.48% |
| Q2 2015 | 2015-06-30 | $130,908 | $31,959 | +32.30% |
| Q1 2015 | 2015-03-31 | $77,705 | −$252,177 | −76.44% |
| Q4 2014 | 2014-12-31 | $71,282 | −$86,613 | −54.85% |
| Q3 2014 | 2014-09-30 | $184,480 | $1,192 | +0.65% |
| Q2 2014 | 2014-06-30 | $98,949 | −$60,685 | −38.02% |
| Q1 2014 | 2014-03-31 | $329,882 | $176,502 | +115.07% |
| Q4 2013 | 2013-12-31 | $157,895 | $31,507 | +24.93% |
| Q3 2013 | 2013-09-30 | $183,288 | $44,383 | +31.95% |
| Q2 2013 | 2013-06-30 | $159,634 | $5,682 | +3.69% |
| Q1 2013 | 2013-03-31 | $153,380 | $64,837 | +73.23% |
| Q4 2012 | 2012-12-31 | $126,388 | −$95,526 | −43.05% |
| Q3 2012 | 2012-09-30 | $138,905 | $5,359 | +4.01% |
| Q2 2012 | 2012-06-30 | $153,952 | $64,330 | +71.78% |
| Q1 2012 | 2012-03-31 | $88,543 | −$32,539 | −26.87% |
| Q4 2011 | 2011-12-31 | $221,914 | — | — |
| Q3 2011 | 2011-09-30 | $133,546 | −$39,317 | −22.74% |
| Q2 2011 | 2011-06-30 | $89,622 | — | — |
| Q1 2011 | 2011-03-31 | $121,082 | — | — |
| Q3 2010 | 2010-09-30 | $172,863 | — | — |
Rockwell Medical capital expenditures (capex) trends
Over the last five fiscal years, Rockwell Medical's capital expenditures (capex) decreased from $1.0M to $542,000, a change of −$504,000. The latest reported quarter, Q2 2026, shows $617,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rockwell Medical source filings ↗